Tremfya

Tremfya (guselkumab) is a biologic medication used to treat plaque psoriasis and psoriatic arthritis. It works by blocking the IL-23 protein, reducing inflammation and controlling immune system overactivity.

Symptoms include thick, red skin plaques with silvery scales, itching, joint pain and stiffness, fatigue, and reduced mobility.

These conditions are caused by an overactive immune system, influenced by genetic factors, hormonal changes, and environmental triggers (e.g., stress, infections).

Diagnosis involves skin examination, blood tests (e.g., inflammation markers), and imaging studies (e.g., X-rays, MRI) for joint assessment.

Tremfya is administered via subcutaneous injection at specific intervals, usually every 8 weeks after initial doses.

Doctors prescribe Tremfya, topical corticosteroids, NSAIDs, and sometimes methotrexate.

Supportive care includes daily skin moisturization, avoiding harsh soaps, hydration, stress management techniques, and sun protection.

Long-term care involves regular skin and joint evaluations, adherence to medication, and infection prevention measures.

While prevention isn’t possible, avoiding triggers, stress management, and regular healthcare monitoring can help reduce flare-ups.